Document is current
Any future updates will be listed below
-
Authors
Barnum, Collin R.
Paviani, Bruna
Couture, Garret
Masarweh, Chad
Chen, Ye https://orcid.org/0000-0002-6379-1968
Huang, Yu-Ping https://orcid.org/0000-0003-3715-6511
Markel, Kasey https://orcid.org/0000-0002-8285-3888
Mills, David A.
Lebrilla, Carlito B.
Barile, Daniela
Yang, Minliang https://orcid.org/0000-0002-4670-7947
Shih, Patrick M. https://orcid.org/0000-0002-2119-3345
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (R00AT009573, R00AT009573, R00AT009573)
- License Information
-
More Information
Article History
Received: 24 August 2023
Accepted: 13 May 2024
First Online: 13 June 2024
Competing interests
: D.A.M., D.B. and C.B.L. are cofounders of Infinant Health, a company focused on probiotic-based manipulation of the infant gut microbiota. D.A.M. and C.B.L. are cofounders of One.Bio, a company advancing new bioactive glycans. None of these companies had any role in the conceptualization, design, analysis or preparation of this manuscript. The other authors declare no competing interests.
